Trial intelligence / Profile preview

Topical steroid versus subconjunctival steroid and miotic after cataract surgery

2006-001486-41Phase 4Completed

Sponsor
Het Oogziekenhuis Rotterdam
Start
Jun 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Postoperative ocular inflammation and ocular inflammation comparing Postoperative topical dexamethasone with Subconjunctival Celestone plus postoperative physostigmine (2 arms). Primary endpoint: Laser flarecount change from baseline to day 21. Started Jun 2006; status: completed.

02

Drugs

betamethasonedexamethasonephysostigmine
03

Conditions

Postoperative ocular inflammationocular inflammation

Beyond the preview

Go deeper on 2006-001486-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001486-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call